SmeBSEOPEN

Amtech Esters IPO

₹71 – ₹71 · Issue Size ₹17.88 Cr

IPO Overview

StatusOpen
Price Band₹71 – ₹71
Issue Size₹17.88 Cr
Lot Size3200 shares
Min Investment₹2,40,000
Face Value₹10
Issue Structure
Fresh Issue₹17.88 Cr
Offer for Sale—
Total Size₹17.88 Cr

Business Model

Competitive Advantages
  • Diversified Product Portfolio Catering to a Broad Customer Base
  • Our diversified product portfolio is one of our key strengths. We are engaged in the manufacturing of Unsaturated
  • Polyester Resins ("UPRs") and trading of complementary products such as Fiber Resin, hardeners, ancillary
  • Our manufacturing vertical comprises various grades of polyester resins, each designed for specific applications and

IPO Timeline

Open Date9 Sept 2026
Close Date11 Sept 2026
Allotment15 Sept 2026
Refund16 Sept 2026
Credit to Demat16 Sept 2026
Listing Date17 Sept 2026

Strengths & Weaknesses

Strengths

  • ✓Diversified Product Portfolio Catering to a Broad Customer Base
  • ✓Our diversified product portfolio is one of our key strengths. We are engaged in the manufacturing of Unsaturated
  • ✓Polyester Resins ("UPRs") and trading of complementary products such as Fiber Resin, hardeners, ancillary
  • ✓Our manufacturing vertical comprises various grades of polyester resins, each designed for specific applications and

Management & Promoters

A
Ajit Singh BawaExecutive Director
I
Indian LLPsNon-Executive Director
G
Gurpreet Kaur BawaNon-Executive Director
I
Indian Public CompaniesIndependent Director
R
Rahul SharmaNon-Executive Director
P
Paras SuriNon-Executive Director
N
Name Ajit Singh BawaManaging Director
E
Equity Shares.Director
I
INTEREST OFDIRECTOR

Shareholding Pattern

Pre-IPO
Category%
Promoters62.35%
Public37.65%

Peer Comparison

CompanyP/EEPS
Amtech Esters IPO——
Delhi-110.0x—
Telephone: +-- Telephone:-91.0x—

Pre-IPO Financials

PeriodRevenue (Cr)PAT (Cr)Net Worth (Cr)Total Assets (Cr)
November 2025₹25.68 Cr₹0.61 Cr₹0.31 Cr₹33.7 Cr
March 2025₹36.89 Cr₹0.05 Cr₹20.23 Cr₹27.86 Cr
March 2024₹24.6 Cr₹0.07 Cr₹0.01 Cr₹24.79 Cr
March 2023₹22.23 Cr₹0.01 Cr—₹12.73 Cr

About

Q-Line Biotech Ltd. (QBL) is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs. The company supplies diagnostic equipment and IVD products for different diagnostic healthcare needs since 2013 directly or through its distributor/s majorly to diagnostic service providers, hospitals and medica

ExchangeBSE
Issue Typesme
Face Value₹10 per share

Documents

rupiya.io is for research and education only. IPO data is sourced from public disclosures (DRHP/RHP). Not investment advice. Validate with SEBI-regulated disclosures before acting.